LEVOFLOXACINE ALMUS 500 mg, film-coated tablet scored 5 tablets
Active ingredients: Levofloxacin, Levofloxacin hemihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored5 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LEVOFLOXACINE ALMUS 500 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 5 comprimé(s)
- Marketing authorisation holder
- ALMUS FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Aug 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68444182CIP74949132CIP133400949491322Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVOFLOXACINE HÉMIHYDRATÉEcomprimé | — | SA |
| LÉVOFLOXACINEcomprimé | 500 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.